Viewing Study NCT00563459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:43 PM
Ignite Modification Date: 2026-04-09 @ 3:56 PM
Study NCT ID: NCT00563459
Status: TERMINATED
Last Update Posted: 2013-01-29
First Post: 2007-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.
Sponsor: SK Life Science, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
None Seizures View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epilepsy, seizures View
None partial onset seizures View
None anti-epileptic drugs (AED) View
None carisbamate View
None topiramate View
None levetiracetam View